---
title: About Orasis Pharmaceuticals | Company Overview
description: "Learn about Orasis Pharmaceuticals: our mission to transform near vision correction, our story, our investors, and our offices in the U.S. and Israel."
image: https://orasis-pharma.com/hubfs/raw_assets/public/orasis-website/images/home-hero-bg.jpg
---
[Skip to content](https://orasis-pharma.com/about#main-content)
[ ](https://orasis-pharma.com?hsLang=en)
- [ About ](https://orasis-pharma.com/about?hsLang=en)
#### [Company Overview Our mission, vision, and story](https://orasis-pharma.com/about?hsLang=en)
#### [Leadership Team Meet the executives driving our vision](https://orasis-pharma.com/leadership?hsLang=en)
#### [Board of Directors Guidance from industry leaders](https://orasis-pharma.com/board?hsLang=en)
#### [Investors Our partners in innovation](https://orasis-pharma.com/investors?hsLang=en)
- [ Qlosi ](https://orasis-pharma.com/qlosi?hsLang=en)
- [ Presbyopia ](https://orasis-pharma.com/presbyopia?hsLang=en)
- News
[Press Releases](https://orasis-pharma.com/press-releases?hsLang=en) [In the Media](https://orasis-pharma.com/in-the-media?hsLang=en)
- [Contact](https://orasis-pharma.com/contact?hsLang=en)
[Qlosi.com](https://qlosi.com?hsLang=en)
Company Overview
# We See Every Day as an Opportunity to Disrupt Conventional Thinking
Because we are a purpose-driven company that moves people to realize their best selves through improved vision.
Our Story
## Delivering Solutions to Reshape Vision Possibilities
Orasis Pharmaceuticals is an ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities. Orasis has developed Qlosi® (pilocarpine HCl ophthalmic solution) 0.4%, a novel corrective eye drop for the treatment of presbyopia, or age-related blurry near vision, in adults.
With deep expertise in eye care, and a willingness to take on challenges, we are committed to transforming the standard of care for near vision correction, with an initial focus on presbyopia, or age-related blurry near vision.
Presbyopia is the gradual loss of your eye’s ability to focus on near objects as a result of the natural aging process, which occurs mostly after the age of 40, and affects almost two billion people globally.
Orasis is led by a collaborative team of industry executives and eye care professionals, whose expertise guides our business, people and principles to make a meaningful difference in the eyecare community.
Orasis is funded by a diverse group of sophisticated and experienced life science and healthcare investors including Arboretum Ventures, Johnson & Johnson Innovation – JJDC, Inc., Catalio Capital Management, Visionary Ventures, Bluestem Capital, SBI (Japan) Innovation Fund, Sequoia Capital, LifeSci Venture Partners, Maverick Ventures Israel and other private investors.
Orasis has offices in the U.S. and Israel.
## Get in Touch
Ready to see what's possible? Contact us here.
[Contact Us](https://orasis-pharma.com/contact?hsLang=en)
[ ](https://orasis-pharma.com/?hsLang=en)
An ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities.
#### Company
[Company Overview](https://orasis-pharma.com/about?hsLang=en) [Leadership Team](https://orasis-pharma.com/leadership?hsLang=en) [Board of Directors](https://orasis-pharma.com/board?hsLang=en) [Investors](https://orasis-pharma.com/investors?hsLang=en)
#### Product
[About Qlosi](https://orasis-pharma.com/qlosi?hsLang=en) [About Presbyopia](https://orasis-pharma.com/presbyopia?hsLang=en) [Qlosi.com](https://qlosi.com?hsLang=en)
#### News & Contact
[Press Releases](https://orasis-pharma.com/press-releases?hsLang=en) [In the Media](https://orasis-pharma.com/in-the-media?hsLang=en) [Contact Us](https://orasis-pharma.com/contact?hsLang=en) [info@orasis-pharma.com](mailto:info@orasis-pharma.com)
©2026 Orasis Pharmaceuticals, Inc. All Rights Reserved. QLOSI®, Orasis Pharmaceuticals, the Orasis Pharmaceuticals logo, and certain other trademarks herein are trademarks of Orasis Pharmaceuticals, Inc.
[Privacy Policy](https://orasis-pharma.com/privacy-policy?hsLang=en) [Terms of Service](https://orasis-pharma.com/terms-of-service?hsLang=en) [Health Data Privacy](https://orasis-pharma.com/health-data-privacy-policy?hsLang=en)
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.orasis-pharma.com/#organization",
"@type" : "Organization",
"address" : {
"@type" : "PostalAddress",
"addressCountry" : "US",
"addressLocality" : "Ponte Vedra",
"addressRegion" : "FL",
"postalCode" : "32081",
"streetAddress" : "203 Fort Wade Rd., #140"
},
"contactPoint" : {
"@type" : "ContactPoint",
"contactType" : "customer service",
"email" : "info@orasis-pharma.com",
"telephone" : "+1-866-672-7471"
},
"description" : "Orasis Pharmaceuticals is an ophthalmic pharmaceutical company delivering solutions to reshape vision possibilities, developer of Qlosi (pilocarpine hydrochloride ophthalmic solution) 0.4% for the treatment of presbyopia in adults.",
"logo" : "https://qlosiecp.com/hubfs/HQ%20Only/Orasis_Pharmaceuticals_Logo_RGB.svg",
"name" : "Orasis Pharmaceuticals",
"sameAs" : [ "https://www.linkedin.com/company/orasis-pharmaceuticals/", "https://twitter.com/OrasisPharma" ],
"url" : "https://www.orasis-pharma.com/"
}
```
```json
{
"@context" : "https://schema.org",
"@id" : "https://www.orasis-pharma.com/#website",
"@type" : "WebSite",
"name" : "Orasis Pharmaceuticals",
"publisher" : {
"@id" : "https://www.orasis-pharma.com/#organization"
},
"url" : "https://www.orasis-pharma.com/"
}
```